2M5B image
Deposition Date 2013-02-19
Release Date 2013-04-17
Last Version Date 2024-10-09
Entry Detail
PDB ID:
2M5B
Keywords:
Title:
The NMR structure of the BID-BAK complex
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Conformers Calculated:
100
Conformers Submitted:
20
Selection Criteria:
structures with the lowest energy
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Bcl-2 homologous antagonist/killer
Gene (Uniprot):BAK1
Chain IDs:A
Chain Length:169
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:human_BID_BH3_SAHB
Chain IDs:B
Chain Length:23
Number of Molecules:1
Biological Source:Synthetic construct
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
MK8 B LEU 2-METHYL-L-NORLEUCINE
NLE B LEU NORLEUCINE
Ligand Molecules
Primary Citation
BID-induced structural changes in BAK promote apoptosis.
Nat.Struct.Mol.Biol. 20 589 597 (2013)
PMID: 23604079 DOI: 10.1038/nsmb.2563

Abstact

The BCL-2-family protein BAK is responsible for mitochondrial outer-membrane permeabilization (MOMP), which leads to apoptosis. The BCL-2 homology 3 (BH3)-only protein BID activates BAK to perform this function. We report the NMR solution structure of the human BID BH3-BAK complex, which identified the activation site at the canonical BH3-binding groove of BAK. Mutating the BAK BH1 in the groove prevented activation and MOMP but not the binding of BID. BAK BH3 mutations allowed BID binding and activation but blunted function by blocking BAK oligomerization. BAK activation follows a 'hit-and-run' mechanism whereby BID dissociates from the trigger site, which allows BAK oligomerization at an overlapping interface. In contrast, the BH3-only proteins NOXA and BAD are predicted to clash with the trigger site and are not activators of BAK. These findings provide insights into the early stages of BAK activation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures